Luminary Therapeutics, Inc.
PrivateLast Round
Grant
Mar 11, 2025
Total Funding Raised
$53.73M
Company Overview
Luminary Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Minneapolis, Minnesota. Its latest recorded funding round was a Grant round in March 2025.
Luminary Therapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic cell therapies using its proprietary gamma delta platform to target solid tumors and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luminary Therapeutics, Inc. Comparables
Compare Luminary Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iCell Gene Therapeutics | 82% | |
| A-SEEDS Co., Ltd. | 81% | |
| Elpis Biopharmaceuticals | 81% |
For institutional investors. Book with your work email.
Luminary Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 11, 2025 | ||||
| Grant | Oct 29, 2024 | ||||
| VC Round | Dec 21, 2022 | ||||
| Series A | Oct 14, 2022 | ||||
| SAFE | Oct 14, 2021 | ||||
SAFE | Mar 25, 2021 |
For institutional investors. Book with your work email.
Luminary Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| ARPA-H | Grant |
| Gopher Angels | Angel, Seed |
| Lunch Pail Ventures | Angel |
| NuFund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
$300K raised from Bio-Techne Corporation, ScaleReady, and Wilson Wolf.
For institutional investors. Book with your work email.
Luminary Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Luminary Therapeutics, Inc.'s valuation, stock price, and market status.
Is Luminary Therapeutics, Inc. a public or private company?
Luminary Therapeutics, Inc. is a private company.
What is the current stock price of Luminary Therapeutics, Inc.?
Luminary Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Luminary Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Luminary Therapeutics, Inc. worth (valuation)?
Valuation information for Luminary Therapeutics, Inc. is not publicly available.
Can I buy Luminary Therapeutics, Inc. stock?
Luminary Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Luminary Therapeutics, Inc.'s last funding round?
Luminary Therapeutics, Inc.'s most recent funding round was Grant on March 11, 2025.
Who are the main investors in Luminary Therapeutics, Inc.?
Key investors in Luminary Therapeutics, Inc. include National Cancer Institute, NIH RADx, ARPA-H, Gopher Angels, Lunch Pail Ventures.
Will Luminary Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Luminary Therapeutics, Inc..
How can I track Luminary Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Luminary Therapeutics, Inc.'s shares on secondary markets.